share_log

At US$69.43, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

At US$69.43, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

美元 69.43 美元,是時候把優異醫療系統公司(NASDAQ:MMSI)放在您的觀察名單上了嗎?
Simply Wall St ·  2022/12/29 07:50

Merit Medical Systems, Inc. (NASDAQ:MMSI), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGS over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine Merit Medical Systems's valuation and outlook in more detail to determine if there's still a bargain opportunity.

美德醫療系統公司(NASDAQ:MMSI)可能不是一個大盤股,但在過去幾個月中,它受到了 NASDAQGS 大幅上漲的關注。由於許多分析師涵蓋了中型股票,我們可能預期任何股價敏感的公告已納入股票價格。但是,股票是否仍然以相對便宜的價格進行交易?讓我們更詳細地研究 Merit 醫療系統的估值和前景,以確定是否仍然有討價還價的機會。

See our latest analysis for Merit Medical Systems

查看我們關於優異醫療系統的最新分析

What Is Merit Medical Systems Worth?

什麼是優點醫療系統值得?

According to my valuation model, the stock is currently overvalued by about 20%, trading at US$69.43 compared to my intrinsic value of $57.69. This means that the buying opportunity has probably disappeared for now. But, is there another opportunity to buy low in the future? Given that Merit Medical Systems's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

根據我的估值模型,股票目前被高估了約 20%,相較於 57.69 美元的價值,交易價格為 69.43 美元。這意味著購買機會現在可能已經消失了。但是,將來是否還有另一個機會購買低價?鑑於 Merit Medical Systems 的份額相當波動(即其價格變動相對於市場其他部分而言被放大),這可能意味著價格可能會下跌,從而為我們提供了另一次購買的機會。這是基於其高 beta 值,這是股價波動的一個很好的指標。

What kind of growth will Merit Medical Systems generate?

美德醫療系統將產生什麼樣的增長?

earnings-and-revenue-growth
NasdaqGS:MMSI Earnings and Revenue Growth December 29th 2022
納斯達基金指數:微波指數收益和收入增長 2022 年 12 月 29 日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Merit Medical Systems' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

尋求投資組合增長的投資者可能希望在購買股票之前考慮公司的前景。儘管價值投資者會認為這是相對於最重要的價格的內在價值,但更具吸引力的投資論文將是以低廉的價格獲得高增長潛力。Merit 醫療系統在未來幾年的收入預計將增加一倍,這表明未來非常樂觀。這應該導致更強大的現金流,進入更高的股票價值。

What This Means For You

這對您意味著什麼

Are you a shareholder? MMSI's optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe MMSI should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

您是股東嗎? MMSI 樂觀的未來增長似乎已被納入當前股價,股票交易高於其公允價值。但是,這帶來了另一個問題-現在是出售的正確時機嗎?如果您認為 MMSI 應該低於其當前價格進行交易,那麼當價格跌至其實際價值時,高價賣出並再次購買它可以獲利。但是在你做出這個決定之前,先看看它的基本面是否已經改變。

Are you a potential investor? If you've been keeping tabs on MMSI for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there's no upside from mispricing. However, the optimistic prospect is encouraging for MMSI, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

您是潛在投資者嗎? 如果您一直在密切關注 MMSI 一段時間,現在可能不是進入股票的最佳時機。價格已經超過了其真正價值,這意味著不會因錯誤而引起。但是,樂觀的前景對 MMSI 來說令人鼓舞,這意味著值得更深入地研究其他因素,以利用下一次價格下跌的優勢。

So while earnings quality is important, it's equally important to consider the risks facing Merit Medical Systems at this point in time. In terms of investment risks, we've identified 1 warning sign with Merit Medical Systems, and understanding it should be part of your investment process.

因此,儘管收益質量很重要,但在此時考慮 Merit 醫療系統面臨的風險同樣重要。在投資風險方面, 我們已經確定 1 個警告標誌 與優異醫療系統,並理解它應該是您投資過程的一部分。

If you are no longer interested in Merit Medical Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您不再對 Merit Medical Systems 感興趣,可以使用我們的免費平台查看我們的 50 多種具有高增長潛力的其他股票的列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?關注內容? 取得聯繫 直接與我們聯繫。 或者,通過電子郵件發送電子郵件給編輯團隊。
這篇文章由簡單牆聖是一般性質. 我們僅使用公正的方法,根據歷史數據和分析師預測提供評論,我們的文章並不打算作為財務建議。 它並不構成購買或出售任何股票的建議,也不會考慮您的目標或您的財務狀況。我們的目標是為您帶來由基本數據驅動的長期集中分析。請注意,我們的分析可能不會考慮最新的價格敏感公司公告或定性材料。簡易華街在提及的任何股票中都沒有倉位。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論